Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice

Psychopharmacology

Volumn 207, Issue 4, 2010, Pages 547-558

  Schmidt, Lene S ^a   Miller, Anthony D ^b   Lester, Deranda B ^b   Bay Richter, Cecilie ^a   Schülein, Christina ^a   Frikke Schmidt, Henriette ^a   Wess, Jürgen ^c   Blaha, Charles D ^b   Woldbye, David P D ^a   Fink Jensen, Anders ^a   Wortwein, Gitta ^a  

^a Rigshospitalet   (Denmark)

^b University of Memphis   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Amphetamine; Cocaine; Dopamine; M5; Muscarinic; Sensitization

Indexed keywords

AMPHETAMINE; COCAINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; MUSCARINIC M5 RECEPTOR;

ADAPTATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG DEPENDENCE; GENE EXPRESSION; HYPERACTIVITY; KNOCKOUT MOUSE; LOCOMOTION; MOUSE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; SENSITIZATION; VENTRAL TEGMENTUM; WILD TYPE;

AMPHETAMINE; ANIMALS; COCAINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RECEPTOR, MUSCARINIC M5;

EID: 72049094005     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-009-1685-2     Document Type: Article

References (39)

1. Badiani A, Robinson TE (2004) Drug-induced neurobehavioral plasticity: the role of environmental context. Behav Pharmacol 15:327-339 (Pubitemid 39238343)
2. Banbury Conference on genetic background in mice (1997) Mutant mice and neuroscience: recommendations concerning genetic background. Neuron 19:755-759
3. Basile AS, Fedorova I, Zapata A, Liu XG, Shippenberg T, Duttaroy A et al (2002) Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proc Natl Acad Sci U S A 99:11452-11457 (Pubitemid 34920946)
4. Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR et al (1996) Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16:714-722 (Pubitemid 26028830)
5. Bolam JP, Francis CM, Henderson Z (1991) Cholinergic input to dopaminergic-neurons in the substantia-nigra - a double immunocytochemical study. Neuroscience 41:483-494
6. Bonner TI, Young AC, Brann MR, Buckley NJ (1988) Cloning and expression of the human and Rat M5 muscarinic acetylcholine-receptor genes. Neuron 1:403-410
7. Brown EE, Damsma G, Cumming P, Fibiger HC (1991) Interstitial 3- methoxytyramine reflects striatal dopamine release: an in vivo microdialysis study. J Neurochem 57:701-707
8. Camps M, Kelly PH, Palacios JM (1990) Autoradiographic localization of dopamine D1 and D2 receptors in the brain of several mammalian species. J Neural Transm Gen Sect 80:105-127 (Pubitemid 20056747)
9. Chergui K, Suaud-Chagny MF, Gonon F (1994) Nonlinear relationship between impulse flow, dopamine release and dopamine elimination in the rat brain in vivo. Neuroscience 62:641-645 (Pubitemid 2143081)
10. Chintoh A, Fulton J, Koziel N, Aziz M, Sud M, Yeomans JS (2003) Role of cholinergic receptors in locomotion induced by scopolamine and oxotremorine-M. Pharmacol Biochem Behav 76:53-61 (Pubitemid 38366167)
11. Dugast C, Suaud-Chagny MF, Gonon F (1994) Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry. Neuroscience 62:647-654 (Pubitemid 24325643)
12. Fink-Jensen A, Fedorova I, Wortwein G, Woldbye DP, Rasmussen T, Thomsen M et al (2003) Role for M5 muscarinic acetylcholine receptors in cocaine addiction. J Neurosci Res 74:91-96 (Pubitemid 37176671)
13. Forster GL, Blaha CD (2003) Pedunculopontine tegmental stimulation evokes striatal dopamine efflux by activation of acetylcholine and glutamate receptors in the midbrain and pons of the rat. Eur J Neurosci 17:751-762
14. Forster GL, Yeomans JS, Takeuchi J, Blaha CD (2002) M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. J Neurosci 22:1-6
15. Franklin KBJ, Paxinos G (1997) The mouse brain in stereotaxic coordinates. Academic, New York
16. Gerlai R (1996) Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurosci 19:177-181
17. Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM (1997) Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists. J Pharmacol Exp Ther 283:7-15 (Pubitemid 27438940)
18. Gonon FG (1988) Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry. Neuroscience 24:19-28
19. Halberda JP, Middaugh LD, Gard BE, Jackson BP (1997) DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse 26:81-92
20. Koob GF (1992) Drugs of abuse - anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184
21. Koob GF, Sanna PP, Bloom FE (1998) Neuroscience of addiction. Neuron 21:467-476
22. Michael DJ, Wightman RM (1999) Electrochemical monitoring of biogenic amine neurotransmission in real time. J Pharm Biomed Anal 19:33-46
23. Oakman SA, Faris PL, Kerr PE, Cozzari C, Hartman BK (1995) Distribution of pontomesencephalic cholinergic neurons projecting to substantia-nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-5869
24. Ohmori T, Abekawa T, Ito K, Koyama T (2000) Context determines the type of sensitized behaviour: a brief review and a hypothesis on the role of environment in behavioural sensitization. Behav Pharmacol 11:211-221 (Pubitemid 30449753)
25. Paxinos G, Franklin KBJ (2001) The mouse brain in stereotaxic coordinates. Academic, San Diego
26. Post RM, Lockfeld A, Squillace KM, Contel NR (1981) Drug- environment interaction: context dependency of cocaine-induced behavioral sensitization. Life Sci 28:755-760 (Pubitemid 11097487)
27. Ralph RJ, Caine SB (2005) Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague- Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/ 2J mice. J Pharmacol Exp Ther 312:733-741
28. Robinson TE, Berridge KC (1993) The neural basis of drug craving - an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291 (Pubitemid 23219500)
29. Robinson TE, Berridge KC (2001) Incentive-sensitization and addiction. Addiction 96:103-114
30. Robinson TE, Berridge KC (2008) The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci 363:3137-3146
31. Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406-433 (Pubitemid 40834286)
32. Thomsen M, Woldbye DP, Woertwein G, Fink-Jensen A, Wess J, Caine SB (2005) Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. Neuropsychopharmacology 30:S88-S88
33. Thomsen M, Wortwein G, Fink-Jensen A, Woldbye DP, Wess J, Caine SB (2007) Decreased prepulse inhibition and increased sensitivity to muscarinic, but not dopaminergic drugs in M5 muscarinic acetylcholine receptor knockout mice. Psychopharmacology (Berl) 192:97-110 (Pubitemid 46673887)
34. Vilaro MT, Palacios JM, Mengod G (1990) Localization of M5 muscarinic receptor messenger-Rna in Rat-brain examined by in situ hybridization histochemistry. Neurosci Lett 114:154-159 (Pubitemid 20188950)
35. Wang HR, Ng K, Hayes D, Gao XR, Forster G, Blaha C et al (2004) Decreased amphetamine-induced locomotion and improved latent inhibition in mice mutant for the M5 muscarinic receptor gene found in the human 15q schizophrenia region. Neuropsychopharmacology 29:2126-2139 (Pubitemid 39578903)
36. Weiner DM, Levey AI, Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor messenger-RNAs in rat basal ganglia. Proc Natl Acad Sci U S A 87:7050-7054 (Pubitemid 20325203)
37. Wise RA (1996) Neurobiology of addiction. Curr Opin Neurobiol 6:243-251
38. Yamada M, Lamping KG, Duttaroy A, Zhang WL, Cui YH, Bymaster FP et al (2001) Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci U S A 98:14096-14101 (Pubitemid 33116030)
39. Yeomans J, Forster G, Blaha C (2001) M5 muscarinic receptors are needed for slow activation of dopamine neurons and for rewarding brain stimulation. Life Sci 68:2449-2456 (Pubitemid 32455681)